SCHEMBL77329

SCHEMBL77329

O=C(O)c1c(Cl)c(Cl)c2c(c1Cl)C1(OC2=O)c2ccc(O)cc2Oc2c(Cl)c(O)c(Cl)c(Cl)c21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMAD3 P84022 2/20 0.47
HPGD P15428 4/20 0.47
ALDH1A1 P00352 4/20 0.47
BRCA1 P38398 3/20 0.47
HSD17B10 Q99714 3/20 0.47
CYP2C9 P11712 2/20 0.47
ALOX15 P16050 2/20 0.47
ALOX12 P18054 2/20 0.47
RECQL P46063 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
THRB P10828 2/20 0.43
MEN1 O00255 2/20 0.43
BLM P54132 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP3A4 P08684 2/20 0.43
CASP1 P29466 2/20 0.43
HIF1A Q16665 2/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
GLB1 P16278 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6700615 0.97 HPGD (0.47) SMAD3HPGDALDH1A1BRCA1HSD17B10
SCHEMBL5148271 0.88 ALDH1A1 (0.59) SMAD3HPGDALDH1A1BRCA1HSD17B10
SCHEMBL202609 0.85 ALDH1A1 (0.50) SMAD3HPGDALDH1A1BRCA1HSD17B10
SCHEMBL5142280 0.83 ALDH1A1 (0.50) SMAD3HPGDALDH1A1BRCA1HSD17B10
SCHEMBL1032008 0.82 ALDH1A1 (0.59) SMAD3HPGDALDH1A1BRCA1HSD17B10
SCHEMBL30887310 0.79 ALDH1A1 (0.63) SMAD3HPGDALDH1A1BRCA1HSD17B10
SCHEMBL29361906 0.79 ALDH1A1 (0.63) SMAD3HPGDALDH1A1BRCA1HSD17B10
SCHEMBL134733 0.79 ALDH1A1 (0.63) SMAD3HPGDALDH1A1BRCA1HSD17B10
SCHEMBL30887311 0.79 ALDH1A1 (0.63) SMAD3HPGDALDH1A1BRCA1HSD17B10
SCHEMBL7095947 0.79 ALDH1A1 (0.50) SMAD3HPGDALDH1A1BRCA1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3990667-B1 METHODS FOR THE SPECIFIC AND SENSITIVE DETECTION OF SARS-COV-2 PASTEUR INSTITUT (FR) 2024-01-31 EP claimed
US-11795515-B2 Methods and reagents for the specific and sensitive detection of SARS-CoV-2 INSTITUT PASTEUR (FR) 2023-10-24 US claimed
WO-2023140597-A1 PRIMER SET FOR DETECTING CHIKUNGUNYA VIRUS 한국표준과학연구원 2023-07-27 WO claimed
US-20220403448-A1 PRIMER, PROBE AND KIT FOR TUBERCULOSIS DIAGNOSIS USING URINE SAMPLE, AND USES THEREOF REPUBLIC OF KOREA(MASAN NATIONAL TUBERCULOSIS HOSPITAL) (KR) 2022-12-22 US claimed
US-20220145367-A1 METHODS FOR DETECTING LEGIONELLA QUEST DIAGNOSTICS INVESTMENTS LLC (US) 2022-05-12 US claimed
EP-3990667-A1 METHODS AND REAGENTS FOR THE SPECIFIC AND SENSITIVE DETECTION OF SARS-COV-2 Institut Pasteur (FR) 2022-05-04 EP claimed
WO-2022071737-A1 RNA REFERENCE MATERIAL OF SARS-COV-2 AND METHOD FOR PROVIDING INFORMATION FOR DIAGNOSIS OF SARS-COV-2 INFECTION USING SAME 한국표준과학연구원 2022-04-07 WO claimed
EP-3918094-A1 METHODS FOR DETECTING LEGIONELLA Quest Diagnostics Investments LLC (US) 2021-12-08 EP claimed
CN-113646444-A Method for detecting legionella 奎斯特诊断投资有限责任公司 2021-11-12 CN claimed
WO-2021176099-A1 METHODS AND REAGENTS FOR THE SPECIFIC AND SENSITIVE DETECTION OF SARS-COV-2 INSTITUT PASTEUR (FR) 2021-09-10 WO claimed
EP-1127162-A4 METHODS AND KITS FOR DETECTION OF $i(CRYPTOSPORIDIUM PARVUM) AMERICAN WATER WORKS CO INC (US) 2004-07-07 EP claimed
US-6664080-B1 Amplification of DNA isolated from said sample using oligonucleotide primers specific for pathogenic E. coli. BAVARIAN NORDIC RESEARCH INSTITUTE (DK) 2003-12-16 US claimed
US-20030148278-A1 Test kit and method for quantitatively detecting genetically modified DNA in foodstuff by means of fluorescence-coupled PCR BIOINSIDE GMBH (DE) 2003-08-07 US claimed
EP-1144676-B1 TEST KIT AND METHOD FOR QUANTITATIVELY DETECTING GENETICALLY MODIFIED DNA IN FOODSTUFF BY MEANS OF FLUORESCENCE-COUPLED PCR GENESCAN ANALYTICS GMBH (DE) 2003-05-07 EP claimed
EP-1238091-A2 METHODS AND COMPOSITIONS FOR THE MANUFACTURE OF REPLICATION INCOMPETENT ADENOVIRUS Genovo, Incorporated (US) 2002-09-11 EP claimed
US-6395517-B1 DETECTION OF PARASITE IN SAMPLE; OBTAIN SAMPLE, CONCENTRATE PARASITE, AMPLIFY PARASITE NUCLEOTIDE SEQUENCES, DETECT AMPLIFIED TARGET NUCLEIC ACID OF PARASITES AMERICAN WATER WORKS COMPANY, INC. 2002-05-28 US claimed
EP-1127162-A1 METHODS AND KITS FOR DETECTION OF $i(CRYPTOSPORIDIUM PARVUM) American Water Works Company, Inc. (US) 2001-08-29 EP claimed
WO-2001044280-A2 METHODS AND COMPOSITIONS FOR THE MANUFACTURE OF REPLICATION INCOMPETENT ADENOVIRUS GENOVO, INC. (US) 2001-06-21 WO claimed
WO-2000026414-A1 METHODS AND KITS FOR DETECTION OF $i(CRYPTOSPORIDIUM PARVUM) AMERICAN WATER WORKS COMPANY, INC. (US) 2000-05-11 WO claimed
WO-1998056953-A1 METHODS FOR THYROID CELL DETECTION JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (US) 1998-12-17 WO claimed